retatrutide benefits clinical trial retatrutide FDA Approval Status 2026: Everything We Know So Far Retatrutide dose schedule: complete week-by-week

If your doctor brings up lifestyle changes first: "Absolutely, I agree that lifestyle modification is foundational

2008;51(suppl 1):S356

GLP-1s for Chronic Kidney Disease GLP-1s for Advanced Liver Disease In August 2025, the FDA approved Wegovy (semaglutide) to treat adults with a type of liver disease called metabolic-associated steatohepatitis (MASH) with moderate to advanced liver scarring (fibrosis), when used alongside diet and exercise

Changes in Fluid Balance: These medications can affect fluid balance in the body, which may result in drier stools

Minimizing waste Every milligram of peptide that degrades before you can use it is wasted money

Trimi covers most of these points in its published materials